Skip to main content

and
  1. Article

    Open Access

    Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study

    This study aimed to explore whether the addition of sarcopenia and visceral adiposity could improve the accuracy of model predicting progression-free survival (PFS) in hepatocellular carcinoma (HCC).

    Yao Liu, Sirui Fu, **angrong Yu, **xiong Zhang, Siyu Zhu, Yang Yang in BMC Cancer (2023)

  2. No Access

    Article

    TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway

    Hepatocellular carcinoma (HCC) is the most common primary liver cancer in the worldwide. Sorafenib is approved for first-line therapy against advanced HCC, but chemo-resistance is still a leading cause of tumo...

    Guosheng Tan, Binhui **e, Na Yu in International Journal of Clinical Oncology (2021)

  3. No Access

    Article

    VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin

    Cisplatin is a commonly used chemotherapy drug for prostate cancer (PC). However, some PCs are resistant to cisplatin treatment, while the molecular mechanisms underlying the resistance of PCs to cisplatin are...

    Feng Liu, Jihong Wang, Qiang Fu, **nru Zhang, Ying Wang, Jialin Liu in Tumor Biology (2016)